Ethyl Vanillin Composition for Muscle Protein Synthesis and Sarcopenia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack effective solutions for muscle diseases such as sarcopenia, muscle atrophy, and muscle degeneration, which are prevalent with aging and lead to significant muscle loss and functional decline.
Innovation Solution
A pharmaceutical composition containing ethyl vanillin or its pharmaceutically acceptable salt, which increases the expression of proteins related to myoprotein synthesis and inhibits myoprotein degradation, promoting muscle differentiation, regeneration, and strengthening by reducing the expression of muscle RING-finger protein-1 and myostatin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for muscle diseases, then existing therapeutic options are limited, but muscle loss and functional decline continue to worsen
Solution Approach 1:
The patent changes the chemical parameter by introducing ethyl vanillin as a novel active ingredient with specific molecular structure (3-ethoxy-4-hydroxybenzaldehyde). This compound activates the IGF-1/AKT/mTOR signaling pathway, fundamentally altering the biochemical parameters of muscle protein synthesis and degradation, thereby resolving the contradiction between limited treatment options and ongoing muscle loss
Solution Approach 2:
The patent uses ethyl vanillin as an intermediary substance that mediates between the external environment and muscle tissue. It acts through intermediate signaling molecules (AKT, mTOR, p70S6K) to transmit the effect of the active ingredient to the ultimate target of muscle protein synthesis, creating a cascade effect that addresses the gap in conventional treatments
2Duration of action of stationary object
If aging progresses, then life expectancy increases, but muscle strength and function deteriorate due to sarcopenia
Solution Approach 1:
The patent applies preliminary action by using ethyl vanillin to proactively activate muscle protein synthesis pathways before significant muscle loss occurs. The compound preemptively stimulates the IGF-1/AKT/mTOR signaling cascade, preparing and maintaining muscle mass in advance, thereby counteracting the inevitable strength deterioration that accompanies extended lifespan
Solution Approach 2:
The patent implements preliminary anti-action by using ethyl vanillin to preemptively inhibit muscle protein degradation through suppression of ubiquitin-proteasome and autophagy-lysosome pathways. This anticipatory inhibition of catabolic processes counteracts the age-related muscle deterioration before it becomes severe, preserving muscle strength throughout the extended lifespan
3Quantity of substance
If ethyl vanillin is administered, then muscle protein synthesis increases and muscle loss is inhibited, but the mechanism of action requires activation of multiple signaling pathways
Solution Approach 1:
The patent applies self-service by using ethyl vanillin to activate the IGF-1 receptor, which then autonomously initiates a self-propagating signaling cascade through IRS1, PI3K, AKT, and mTOR. The system serves itself by using the active ingredient to trigger an internal amplification mechanism that automatically increases muscle protein synthesis without requiring external intervention at each step of the pathway
Data Source
AI summary
The present invention relates to a composition comprising ethyl vanillin or a pharmaceutically acceptable salt thereof as an effective ingredient for preventing or treating muscle disease or for improving a muscle function. Having the capability of upregulating the expression of a protein associated with muscle protein synthesis and muscle mass increase in myocytes and downregulating at an mRNA level the expression of an enzyme involved in muscle protein degradation, ethyl vanillin can exhibit effects of muscle differentiation, muscle regeneration, and muscle strengthening through an increase in muscle mass against muscle diseases attributed to muscle function decrease, muscle consumption, or muscle degradation and can suppress sarcopenia. Thus, ethyl vanillin can be used for preventing or treating muscle diseases or for promoting muscle differentiation, muscle regeneration and muscle strengthening, muscle mass increase, or muscle generation or for improving muscle function.